Xie W - Search Results

1

A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases.

Lee RJ, Saylor PJ, Michaelson MD, Rothenberg SM, Smas ME, Miyamoto DT, Gurski CA, Xie W, Maheswaran S, Haber DA, Goldin JG, Smith MR. Lee RJ, et al. Among authors: xie w. Clin Cancer Res. 2013 Jun 1;19(11):3088-94. doi: 10.1158/1078-0432.CCR-13-0319. Epub 2013 Apr 3. Clin Cancer Res. 2013. PMID: 23553848 Free PMC article.

2

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.

Nakabayashi M, Xie W, Regan MM, Jackman DM, Kantoff PW, Oh WK. Nakabayashi M, et al. Among authors: xie w. Cancer. 2006 Sep 1;107(5):975-81. doi: 10.1002/cncr.22085. Cancer. 2006. PMID: 16862573 Free article.

3

Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer.

Taplin ME, Xie W, Bubley GJ, Ernstoff MS, Walsh W, Morganstern DE, Regan MM. Taplin ME, et al. Among authors: xie w. J Clin Oncol. 2006 Dec 1;24(34):5408-13. doi: 10.1200/JCO.2006.06.6589. J Clin Oncol. 2006. PMID: 17135641 Clinical Trial.

4

Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.

Xie W, Nakabayashi M, Regan MM, Oh WK. Xie W, et al. Cancer. 2007 Dec 15;110(12):2709-15. doi: 10.1002/cncr.23111. Cancer. 2007. PMID: 17960608 Free article.

5

Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer.

Ross RW, Oh WK, Xie W, Pomerantz M, Nakabayashi M, Sartor O, Taplin ME, Regan MM, Kantoff PW, Freedman M. Ross RW, et al. Among authors: xie w. J Clin Oncol. 2008 Feb 20;26(6):842-7. doi: 10.1200/JCO.2007.13.6804. J Clin Oncol. 2008. PMID: 18281655

6

Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect.

Ross RW, Xie W, Regan MM, Pomerantz M, Nakabayashi M, Daskivich TJ, Sartor O, Taplin ME, Kantoff PW, Oh WK. Ross RW, et al. Among authors: xie w. Cancer. 2008 Mar 15;112(6):1247-53. doi: 10.1002/cncr.23304. Cancer. 2008. PMID: 18293426 Free article. Clinical Trial.

7

Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.

Raje N, Woo SB, Hande K, Yap JT, Richardson PG, Vallet S, Treister N, Hideshima T, Sheehy N, Chhetri S, Connell B, Xie W, Tai YT, Szot-Barnes A, Tian M, Schlossman RL, Weller E, Munshi NC, Van Den Abbeele AD, Anderson KC. Raje N, et al. Among authors: xie w. Clin Cancer Res. 2008 Apr 15;14(8):2387-95. doi: 10.1158/1078-0432.CCR-07-1430. Clin Cancer Res. 2008. PMID: 18413829

8

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK. Choueiri TK, et al. Among authors: xie w. Cancer. 2009 Mar 1;115(5):981-7. doi: 10.1002/cncr.24064. Cancer. 2009. PMID: 19152438 Free PMC article.

9

High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.

Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N. Pozzi S, et al. Among authors: xie w. Clin Cancer Res. 2009 Sep 15;15(18):5829-39. doi: 10.1158/1078-0432.CCR-09-0426. Epub 2009 Sep 8. Clin Cancer Res. 2009. PMID: 19737962

10

Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.

Sun T, Lee GS, Oh WK, Pomerantz M, Yang M, Xie W, Freedman ML, Kantoff PW. Sun T, et al. Among authors: xie w. Clin Cancer Res. 2010 Nov 1;16(21):5244-51. doi: 10.1158/1078-0432.CCR-10-1261. Epub 2010 Sep 20. Clin Cancer Res. 2010. PMID: 20855462 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,739 results

Search Page

Filters